louisakewell, Author at European Medical Journal - Page 43 of 153

Continue
24th April 2017

EAU 2017 – Congress Highlights

Our full congress review of EAU 2017 will be available soon in our Urology 5.1 eJournal, but for now take a look at the highlights from this year’s event…
24th April 2017

EAU 2017 – Interview – Dr Riccardo Autorino

An interview with Dr Riccardo Autorino (Case Medical Center, USA) at this year’s EAU congress held in London, UK.
3 Mins
20th April 2017

Polyganics Announces Enrollment of the First Patient in its PROTECT NEURO Study

Groningen, The Netherlands, April 20, 2017 – Polyganics, a privately held medical technology company focused on the commercialization of proprietary…
5 Mins
18th April 2017

RedHill Biopharma Receives Notice of Allowance for Two Additional U.S. Patents Covering BEKINDA®

Tel-Aviv, Israel, April 18, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty…
2 Mins
11th April 2017

LifeCodexx and Charité to Form Research Alliance Following Successful Clinical Proof-Of Principle for Molecular Genetic-Based Preeclampsia Assay

Konstanz/Berlin, Germany, April 11, 2017 – LifeCodexx AG, a leading European NIPT provider, and the Department of Obstetrics of the Charité have formed a…
2 Mins
11th April 2017

The UK Should Look to Digital Platforms to Improve Services for Mental Health Sufferers

An online therapy service in Finland is assisting mental health individuals who feel they cannot go to see a therapist/doctor in confidence. First set up…
2 Mins
6th April 2017

Asceneuron Receives Regulatory Approval for Phase I Healthy Volunteer Study of Oral Tau Inhibitor

Lausanne, Switzerland, April 06, 2017 – Asceneuron SA, an emerging leader in the development of innovative small molecules for neurodegenerative diseases…
7 Mins
5th April 2017

RedHill Biopharma Receives FDA Orphan Drug Designation for YELIVA® for the Treatment of Cholangiocarcinoma

Tel-Aviv, Israel, April 04, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty…
3 Mins
5th April 2017

Australia’s Bionic Vision Technologies Raises US$18 Million (AU$23.5 M) to Develop ‘Bionic Eye’ for Global Markets

Melbourne, Australia, April 03, 2017 – Retinal implant innovator Bionic Vision Technologies (BVT) today announced it had raised US $18 million…
2 Mins
5th April 2017

Imanova Receives £1M Award from the MRC To Develop Early Markers of Dementia –The MIND-MAPS Study

London, UK, April 03, 2017 – Following a £0.5m Medical Research Council (MRC) grant to implement new Positron Emission Tomography (PET) imaging tracers…